Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro

Citation
Mm. Knupfer et al., Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro, ANTICANC R, 18(5A), 1998, pp. 3585-3589
Citations number
27
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
18
Issue
5A
Year of publication
1998
Pages
3585 - 3589
Database
ISI
SICI code
0250-7005(199809/10)18:5A<3585:VAIPAC>2.0.ZU;2-E
Abstract
Recently we were able to show that valproic acid (WA) induces growth-arrest and differentiation of human neuroblastoma cells. Hence we investigated in vitro the antitumoral effects of VPA on malignant gliomas by determining c ell proliferation and expression of CD56 and CD44 of human T98G, A172, 85HG 66, 86HG39 and rat C6 cell lines. VPA at concentrations ranging from 0.1 to I mM strongly inhibited proliferation of A172, 86HG39, 85HG66 and C6 cells in a dose-dependent manner,whereas T98G cell growth remained unchanged. Al l human glioma cells were highly positive for CD44, whereas CD56 was differ ently expressed. After 7 days of incubation with 1mM VPA CD56 expression wa s markedly increased in T98G, A172 and 85HG66 cells, whereas CD44 expressio n was decreased in all human cell lines. These data suggest that VPA has an titumoral effects on malignant glioma cells. Therefore we consider VPA as a potent therapeutic agent for treatment of these tumors.